Team

Core team

Gabriela Jiménez Valerio, PhD.

Co-founder & CEO

Educated in biomedicine and pharmaceutical industry with business-oriented mindset and leadership skills.

Oriol Casanovas Casanovas, PhD.

Co-founder & CSO

His research has been focused on determining tumor adaptation and resistance to anti-angiogenic cancer therapy.

Advisors

Bart Huisken, MBA.

Co-founder & Strategic Advisor

Richard Roberts, PhD.

Medicinal Chemistry Advisor

Ramón Salazar, MD, PhD.

Clinical Oncology Expert

Research team

Our academic founders have played a key role in demonstrating that resistance to cancer therapy occurs in response to adaptive mechanisms of tumor cells.

We are part of the Program Against Cancer Therapeutic Resistance (ProCURE)

We research angiogenesis and tumor malignization

We are always looking for new talent to join our team